GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Corona Remedies Ltd
Corona Remedies Ltd approves FY26 results, recommends ₹10 final dividend
RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 11 May 2026, 05:28 PM IST  ·  BSE ID: 12049255-030b-479e-97dc-11f8183904ed
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its annual financial results, proposed a ₹10 dividend per share, and appointed new auditors.
🤖 AI Summary
  • Corona Remedies Ltd Board approved audited standalone and consolidated financial results for FY2025-26.
  • Recommended final dividend of ₹10 (100%) per equity share of ₹10 each for shareholder approval.
  • Friday, June 19, 2026, fixed as Record Date for final dividend entitlement.
  • Approved M/s. Walker Chandiok & Co LLP as Statutory Auditor for five years (FY2026-27 to FY2030-31), subject to AGM approval.
  • Approved re-appointment of Dr. Kirtikumar Mehta as Non-Executive Director and Chairman for five years from April 01, 2027.
🏢 How This Affects the Company
💰
Financial Impact
The recommended dividend of ₹10 per equity share, if approved, will result in an outflow of funds to shareholders.
⚙️
Operational Impact
The appointment of new statutory auditors and re-appointment of internal and secretarial auditors establishes key oversight functions for the next five financial years. Re-appointment of the Chairman ensures leadership continuity.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must hold shares by June 19, 2026, to be eligible for the recommended final dividend of ₹10 per share, if declared at the AGM.
👤
Who Is Affected
Shareholders on record as of Friday, June 19, 2026, will be entitled to receive the final dividend of ₹10 per equity share, upon its declaration by members at the Annual General Meeting.
🔍
Management Signal
Management intends to distribute profits to shareholders through a dividend and ensure continuity of governance functions through auditor and director re-appointments.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Annual General Meeting date — for shareholder approval of dividend and auditor appointments.
Dividend payment date — watch for payment on or before August 07, 2026.
Audited financial statements details — for comprehensive revenue and profit figures from 'Annexure A'.
LOW RISK The filing primarily consists of routine board approvals and a dividend recommendation, indicating standard corporate operations.
💡 Investor Takeaway
Corona Remedies Ltd's Board approved FY2025-26 financial results and recommended a final dividend of ₹10 (100%) per equity share. June 19, 2026, is the record date for this dividend, subject to shareholder approval at the AGM.
⚖️ Strengths & Concerns

✅ Positives

  • Recommendation of ₹10 (100%) final dividend per equity share indicates financial position supporting shareholder distribution.
  • Appointment of M/s. Walker Chandiok & Co LLP as Statutory Auditor for five years demonstrates proactive governance and stability.
📅 Company Track Record
Corona Remedies Ltd's Board recommended a final dividend of ₹10 (100%) for FY26, consistent with the previous Board meeting update on May 11, 2026, which also approved the FY26 results.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.